Frequency Therapeutics, Inc.(NasdaqGS:FREQ) dropped from Russell 3000E Index
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
50.05 USD | -0.38% | -7.33% | +4.42% |
05-14 | Korro Bio Q1 Net Loss Shrinks; Kemi Olugemo Appointed as Chief Medical Officer | MT |
04-24 | Korro Bio Insider Bought Shares Worth $999,992, According to a Recent SEC Filing | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.42% | 464M | |
+29.03% | 49.18B | |
-0.10% | 42.11B | |
+47.02% | 40.37B | |
-5.26% | 28.85B | |
+11.48% | 26.09B | |
-22.74% | 18.71B | |
+9.06% | 13.26B | |
+30.01% | 12.32B | |
-1.51% | 11.99B |
- Stock Market
- Equities
- KRRO Stock
- News Korro Bio, Inc.
- Frequency Therapeutics, Inc.(NasdaqGS: FREQ) dropped from Russell 3000E Index